Global Intraoperative Fluorescence Imaging Market Size Is Poised To Reach USD 2330.0 Million By 2035 | CAGR Of 11.85%

Global Intraoperative Fluorescence Imaging Market Size Is Poised To Reach USD 2330.0 Million By 2035

According To A Research Report Published By Spherical Insights & Consulting, The Global Intraoperative Fluorescence Imaging Market Is Expected To Grow From USD 680.0 Million In 2024 To USD 2330.0 Million By 2035, At A CAGR Of 11.85% During The Forecast Period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the Global Intraoperative Fluorescence Imaging Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Devices, Imaging Agents, Fluorescein Sodium, and Others), By Light Source (Laser Diodes, Light Emitting Diodes, and Filtered Lamp Source), By End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.  https://www.sphericalinsights.com/reports/intraoperative-fluorescence-imaging-market        

The intraoperative fluorescence imaging market refers to the worldwide industry that includes specialized surgical imaging devices in which light-activated dyes (commonly ICG) are used for providing real-time visualization of tissues, blood vessels, and tumors during surgery. Intraoperative fluorescence imaging is an intraoperative angiography-like imaging modality using fluorescent indocyanine green excited with laser light. There is an increasing technological advancement, especially the combination of near infrared fluorescence (NIRF) imaging and artificial intelligence (AI), which has improved real-time visualization during surgery and accuracy. An increasing prevalence of complex diseases requiring surgical intervention, along with the growing R&D activities in fluorophores is propelling the market growth. On the contrary, the high cost and limited availability of skilled professionals are challenging the intraoperative fluorescence imaging market.

The devices segment dominated the market with the largest share of around 62.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the intraoperative fluorescence imaging market is divided into devices, imaging agents, fluorescein sodium, and others. Among these, the devices segment dominated the market with the largest share of around 62.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Intraoperative fluorescence imaging devices like KARL STORZ IMAGE1 S Rubina or Fluobeam-800 provide real-time, image-guided surgery using near-infrared (NIR) fluorescence. Further, the device’s advanced visualization capability and widespread adoption in surgical procedures are responsible for propelling market growth.

The laser diodes segment accounted for the dominant market share of about 45.0% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the light source, the intraoperative fluorescence imaging market is divided into laser diodes, light emitting diodes, and filtered lamp source. Among these, the laser diodes segment accounted for the dominant market share of about 45.0% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Laser diodes are highly effective light sources for intraoperative fluorescence imaging. The high excitation efficiency, narrow wavelength specificity, and higher signal-to-noise ratio in near-infrared imaging are driving the market.

The hospitals segment dominated the market with the largest share of over 50.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the intraoperative fluorescence imaging market is divided into hospitals, clinics, and ambulatory surgical centers. Among these, the hospitals segment dominated the market with the largest share of over 50.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period. An increased accessibility of advanced infrastructure and skilled professionals is propelling the segmental market growth.

North America is expected to hold the majority share of the global Intraoperative Fluorescence Imaging market during the forecast period.

North America is expected to hold the majority share of about 35.0% in the global Intraoperative Fluorescence Imaging market during the forecast period. The U.S. is leading the North America intraoperative fluorescence imaging market, due to increased demand for precision in minimally invasive surgeries and rising cancer prevalence. North America has a robust market ecosystem due to the upsurging demand for enhanced surgical precision in oncology and cardiovascular procedures. Further, the presence of key players like Stryker, Medtronic, and KARL STORZ contributes to the market growth.     

Asia Pacific is anticipated to grow at the fastest pace in the global intraoperative fluorescence imaging market during the forecast period. Japan is the leading country in the region’s market, owing to the presence of advanced healthcare infrastructure and significant investment in medical devices. In the Asia Pacific intraoperative fluorescence imaging market, rising adoption of advanced imaging technologies like C-arms, iMRI, and iCT, which enhance surgical precision and patient outcomes, is propelling the market.  

Major vendors in the global intraoperative fluorescence imaging market are Stryker Corporation, KARL STORZ SE & Co. KG, Hamamatsu Photonics K.K., Olympus Corporation, Getinge AB, Leica Microsystems (Danaher Corporation), Quest Medical Imaging B.V., Medtronic plc, Shimadzu Corporation, PerkinElmer Inc., Fluoptics, OnLume Inc., VisionSense, Carl Zeiss Meditec AG, and Novadaq Technologies, and Others.   

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In March 2026, Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study to confirm the safety and efficacy of abenacianine to visualize tumors during lung cancer surgery.
• In December 2025, PNAS published a research article entitled ‘Guiding esophagectomy with intraoperative NIR-II fluorescence video imaging and rapid computation’.

• In November 2024, Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, announced LUMISIGHT (pegulicianine) was granted a permanent Healthcare Common Procedure Coding System (HCPCS) code for Hospital Outpatient Prospective Payment System (OPPS) by the Centers for Medicare & Medicaid Services (CMS).  

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the intraoperative fluorescence imaging market based on the below-mentioned segments:

Global Intraoperative Fluorescence Imaging Market, By Product Type

• Devices
• Imaging Agents
• Fluorescein Sodium
• Others

Global Intraoperative Fluorescence Imaging Market, By Light Source

• Laser Diodes
• Light Emitting Diodes
• Filtered Lamp Source

Global Intraoperative Fluorescence Imaging Market, By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

 Global Intraoperative Fluorescence Imaging Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.  Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter